Better Therapeutics- Tradeable Rights - March 2021 Other Current Liabilities

Better Therapeutics- Tradeable Rights - March 2021 (MCADR) currently reports a other current liabilities of $4M as of September 2023. That compares with $4.9M in the prior-year period — down 17.9% year over year. Use the charts on this page to explore Better Therapeutics- Tradeable Rights - March 2021's other current liabilities history and peer comparisons.

Better Therapeutics- Tradeable Rights - March 2021's other current liabilities decreased from $4.9M to $4M — a 17.9% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Better Therapeutics- Tradeable Rights - March 2021 reported $4M in other current liabilities as of September 2023. That compares with $4.9M in the prior-year period — down 17.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Better Therapeutics- Tradeable Rights - March 2021, and consider following MCADR for alerts when major investors trade the stock.